Web www.globalrph.com
PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.  References     Disclaimer  

Lamivudine
Epivir ®

Lamivudine/Zidovudine
Combivir ®
Usual Dosing (Adults)

HIV: 150mg po q12h or 300mg po qd.
Hepatitis B (Epivir-HBV ®): 100mg po qd.

Combivir ®: [150mg lamivudine/ 300mg AZT]: 1 tablet bid.

Renal Dosing
Lamivudine-Epivir ®:
HIV:
[CRCL > 50]: No changes
[30-49]: 150mg po qd.
[15-29]: 150mg po x 1, then 100mg po qd.
[5-14]: 150mg x 1, then 50mg qd.
[<5]: 50mg x 1, then 25mg qd.

Hepatitis B:
[CRCL > 50]: No changes
[30-49]: 100mg po x 1, then 50mg po qd.
[15-29]: 100mg po x 1, then 25mg po qd.
[5-14]: 35mg po x 1, then 15mg po qd.
[<5]: 35mg po x 1, then 10mg po qd.

-----------------
Lamivudine/Zidovudine - Combivir ®:
[CRCL >50 ml/min]:  No changes.
[<50]:Give each agent separately and adjust based on respective renal dosing guidelines.
Hemodialysis
Lamivudine- Epivir ®:
HIV: 50mg x 1, then 25-50mg qd.
Hepatitis B: 35mg po x 1, then 10mg po qd.

Lamivudine/Zidovudine - Combivir ®:
Give each agent separately and adjust based on respective renal dosing guidelines.


 

 

Contact . Privacy PolicyDisclaimer

Copyright  © GlobalRPh Inc.